Emanuel Finet is staff in the section of heart failure and transplantation medicine, medical director of the metabolic exercise testing center at the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic.
In adults with HF with preserved or mildly reduced ejection fraction, neprilysin inhibition with sacubitril/valsartan did not impair cognitive function compared with valsartan, according to a speaker.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.